PHARMACEUTICALS
South Africa's Aspen Pharmacare said on Thursday first-half earnings rose 26%, buoyed by a strong result from therapeutic focused brands and positive performance of the pharmaceutical business in its home market. Aspen, which counts developed Europe as its biggest revenue generator, has been transforming itself into a therapeutically focused multinational pharmaceutical group rather than one that just makes tablets.
This content is only available to subscribers.
Forgot your password? Click here
Don't have any login details?
Free Trial Access
